Aralez Pharmaceuticals Canada Inc.

Aralez Pharmaceuticals Canada Inc. company information, Employees & Contact Information

A Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products. The Company's products target several therapeutic areas, including pain, allergy and dermatology. Miravo’s head office is located in Mississauga, Ontario, Canada, the international operations are located in Dublin, Ireland and its manufacturing facility is located in Varennes, Québec, Canada. The Varennes facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration. Miravo trades on the TSX: NRI and OTCQX: NRIFF.

Company Details

Employees
20
Address
6733 Mississauga Rd, 800,canada
Phone
(905)876-1118
Email
in****@****lez.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
aralez.com
HQ
Mississauga, Ontario
Looking for a particular Aralez Pharmaceuticals Canada Inc. employee's phone or email?

Aralez Pharmaceuticals Canada Inc. Questions

News

AstraZeneca to sell US rights to Toprol-XL to Aralez Pharmaceuticals - FirstWord Pharma

AstraZeneca to sell US rights to Toprol-XL to Aralez Pharmaceuticals FirstWord Pharma

Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets - PR Newswire

Aralez Pharmaceuticals To Enter Into Purchase Agreements To Sell Substantially All Assets PR Newswire

Aralez Sells Off Assets as it Initiates Bankruptcy Proceedings - BioSpace

Aralez Sells Off Assets as it Initiates Bankruptcy Proceedings BioSpace

ARLZ: A Strong Management Team and Plenty of Capital Makes Aralez a Top Specialty Pharmaceutical Pick… - Zacks Small Cap Research

ARLZ: A Strong Management Team and Plenty of Capital Makes Aralez a Top Specialty Pharmaceutical Pick… Zacks Small Cap Research

With $25M-plus Aralez deal, Merck finds a buyer for abandoned clot-fighter Zontivity - Fierce Pharma

With $25M-plus Aralez deal, Merck finds a buyer for abandoned clot-fighter Zontivity Fierce Pharma

Nuvo Pharmaceuticals™ Announces Completion of the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets - PR Newswire Canada

Nuvo Pharmaceuticals™ Announces Completion of the Acquisition of Aralez Pharmaceuticals Canada, U.S. and International Rights to Vimovo® and other Related Assets PR Newswire Canada

Ocugen Appoints Sanjay S. Subramanian, MBA, as Chief Financial Officer - Ocugen

Ocugen Appoints Sanjay S. Subramanian, MBA, as Chief Financial Officer Ocugen

Aralez Reports New Efficacy & Safety Data for Yosprala at AHA 2016 - drugdiscoverytrends.com

Aralez Reports New Efficacy & Safety Data for Yosprala at AHA 2016 drugdiscoverytrends.com

Aralez Announces Issuance Of Additional U.S. Patent For Yosprala - PR Newswire

Aralez Announces Issuance Of Additional U.S. Patent For Yosprala PR Newswire

Noncanonical Amino Acids Made by Enzymes - CHEManager

Noncanonical Amino Acids Made by Enzymes CHEManager

Resilience Awarded Nearly $17.5 Million To Expand Manufacturing - Pulse 2.0

Resilience Awarded Nearly $17.5 Million To Expand Manufacturing Pulse 2.0

Why Aralez Pharmaceuticals Inc. Got Slaughtered Today - The Motley Fool

Why Aralez Pharmaceuticals Inc. Got Slaughtered Today The Motley Fool

Ambitious Aralez adds AstraZeneca’s Toprol to its expanding CV portfolio - Fierce Pharma

Ambitious Aralez adds AstraZeneca’s Toprol to its expanding CV portfolio Fierce Pharma

Nuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals - PR Newswire Canada

Nuvo Pharmaceuticals™ Announces Signing of Definitive Agreements to Acquire Commercial Products and Infrastructure from Aralez Pharmaceuticals PR Newswire Canada

Pozen, Inc., Tribute to Unite Under Newly Formed Aralez Label - BioSpace

Pozen, Inc., Tribute to Unite Under Newly Formed Aralez Label BioSpace

Aralez Completes Acquisition of Toprol-XL And its Authorized Generic from AstraZeneca - drugdiscoverytrends.com

Aralez Completes Acquisition of Toprol-XL And its Authorized Generic from AstraZeneca drugdiscoverytrends.com

Aralez Completes Acquisition Of Toprol-XL® And Its Authorized Generic From AstraZeneca - PR Newswire

Aralez Completes Acquisition Of Toprol-XL® And Its Authorized Generic From AstraZeneca PR Newswire

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers - BioSpace

Aralez Announces FDA Approval Of YOSPRALA For Secondary Prevention Of Cardiovascular And Cerebrovascular Events In Patients At Risk For Aspirin-Associated Gastric Ulcers BioSpace

Aralez Announces District Court Decision to Uphold VIMOVO (Naproxen/Esomeprazole Magnesium) Patents - PR Newswire Canada

Aralez Announces District Court Decision to Uphold VIMOVO (Naproxen/Esomeprazole Magnesium) Patents PR Newswire Canada

Top Aralez Pharmaceuticals Canada Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant